INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Net Current Assets History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹384 Cr | ₹349 Cr | ₹216 Cr | ₹104 Cr | ₹93 Cr |
What is the latest Net Current Assets ratio of INDOCO REMEDIES ?
Year | Net Current Assets |
---|---|
Mar2023 | ₹384 Cr |
Mar2022 | ₹349 Cr |
Mar2021 | ₹216 Cr |
Mar2020 | ₹104 Cr |
Mar2019 | ₹93 Cr |
How is Net Current Assets of INDOCO REMEDIES Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2023 | ₹384 Cr | 10.01 | |
Mar2022 | ₹349 Cr | 61.76 | |
Mar2021 | ₹216 Cr | 107.08 | |
Mar2020 | ₹104 Cr | 12.50 | |
Mar2019 | ₹93 Cr | - |
Compare Net Current Assets of peers of INDOCO REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDOCO REMEDIES | ₹3,029.2 Cr | 0.2% | -2% | 4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹360,920.0 Cr | -2.3% | -6.5% | 55.3% | Stock Analytics | |
CIPLA | ₹113,794.0 Cr | 4.1% | -4.8% | 55.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹106,860.0 Cr | 7.8% | 17.4% | 20.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,316.0 Cr | 4% | 0.8% | 29.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,380.9 Cr | -1.2% | -5.2% | 83.9% | Stock Analytics |
INDOCO REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDOCO REMEDIES | 0.2% |
-2% |
4% |
SENSEX | 0.9% |
1.5% |
23.6% |
You may also like the below Video Courses